QQQI’s 14% Yield Erases a $500,000 Cost Basis in Seven Years, Then the Tax Bill Lands
QQQI's 14% yield sends monthly checks that feel like income, but the math hiding inside your annual 1099 could turn…
QQQI's 14% yield sends monthly checks that feel like income, but the math hiding inside your annual 1099 could turn…
Retroactive lump sums are landing in the bank accounts of retired teachers, cops, and firefighters after the WEP and GPO…
Leopold Aschenbrenner built one of the most concentrated AI bets in hedge fund history, and then watched it come apart…
Two investors can hold the same S&P 500 covered-call ETF, collect the same monthly distributions, and walk away with very…
Most people assume Medicare will cover the cost of aging in place or moving to a facility, and most people…
Claiming Social Security at 62 sounds like an early ticket to freedom, but the reality of living on that reduced…
Taking part of your paycheck in livestock can shrink a retirement benefit that cash wages would have built, and most…
Bitcoin ETFs just posted their worst outflow week in over a month, and the Strait of Hormuz may have more…
Reddit just retired a key user metric the moment it started showing cracks, and at least one investor thinks that…
Masayoshi Son just placed an enormous bet on a single American chipmaker, and the move has already turned against him…
Top investors who nearly doubled their money on Alphabet are now publicly questioning whether the stock they once called the…
Jim Cramer called packaged food stocks 'so hated' right now, but the data behind the sentiment tells a more complicated…
A child safety trial opening Tuesday in federal court is hammering Meta Platforms stock and pulling Pinterest and Snap down…
Most Americans dread running out of money in retirement, yet millions of retirees refuse to touch the savings they have.…
DigitalOcean is surging while the rest of cloud infrastructure slides lower, and the catalyst is a product launch built entirely…
Something is splitting the ad tech world in two this year, with buy-side platforms bleeding out while sell-side names surge,…
Pembrolizumab infusions can run into five figures per round, and Original Medicare attaches a percentage to every single one with…
Amazon has quietly built a chip business that top investors say rivals the biggest names in semiconductors, yet the stock…
Two of the most powerful CEOs in tech are running surprisingly similar playbooks, but the numbers reveal a clear winner…
A handful of monthly-pay ETFs pull income from three completely different corners of the market, and the one most investors…